亞太科技(002540.SZ)擬回購5000萬元-1億元股份 回購價不超6元/股
格隆匯12月2日丨亞太科技(002540.SZ)公佈,公司基於對公司未來發展前景的信心以及對公司價值的高度認可,為有效維護廣大股東利益,增強投資者信心,促進公司的長遠發展,同時進一步完善公司長效激勵機制,保持公司長久持續運營能力,綜合考慮公司的財務狀況,公司擬以不超過人民幣1億元(含1億元),且不低於人民幣5000萬元(含5000萬元)的公司自有資金通過集中競價交易方式回購公司部分社會公眾股份,用於股權激勵計劃、員工持股計劃。回購價格不超過人民幣6元/股,期限為股東大會審議通過回購股份方案之日起12個月內。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.